Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts.

作者: Rita Falcioni , Jim W. Wesley , Stephen J. Kennel

DOI:

关键词:

摘要: Detailed evaluations of the microdistribution 125I-labeled monoclonal antibodies (MoAbs) to normal tissue antigens were conducted in BALB/c mice. MoAb 273-34A, which binds a target molecule on lumenal surface lung endothelial cells, localizes quickly and efficiently throughout vasculature. 133-13A, an antigen macrophage-like cells expressed nearly equal amounts lung, liver, spleen, most spleen less well liver lung. The 133-13A is consistent with distribution these organs, but more diffuse observed, indicating poor access antigen-positive alveolar macrophages. These findings are hypothesis that tight endothelium (lung) represents significant barrier extravasation into while fenestrated (spleen) sinusoidal (liver) easily penetrated. In human tumor bearing nu/nu mice, beta 4 alpha 6 subunits integrin was studied. MoAbs do not cross-react murine integrins thus tumor-specific mouse model. Localization 450-11A, reacts intercellular domain integrin, very weak diffuse. All extracellular domains (mouse 450-9D, 450-30A1, rat 439-9B) localize tumor. Microdistribution 3 different tumors nonuniform heavy near blood vessels, whereas as determined by immunoperoxidase shows much uniform pattern tumors. experiments 439-9B F(ab')2, changed. Gross doses percent injected dose per g at 48 h did vary significantly (P greater than 0.1) up 500 micrograms/mouse, active recovered comparable serum from animals all doses. contrast, high low At 100 perivascular obtained, micrograms/mouse distributed evenly data indicate penetrate deeply portions distant vessels.(ABSTRACT TRUNCATED AT 400 WORDS)

参考文章(27)
Rakesh K. Jain, Eva Marie Sevick, Geometric resistance to blood flow in solid tumors perfused ex vivo: effects of tumor size and perfusion pressure. Cancer Research. ,vol. 49, pp. 3506- 3512 ,(1989)
David M. Goldenberg, Rosalyn D. Blumenthal, Hans J. Hansen, Robert M. Sharkey, Biological considerations for radioimmunotherapy. Cancer Research. ,vol. 50, ,(1990)
Jeffrey Schlom, Jorge A. Carrasquillo, Andrew Raubitschek, Patricia Horan Hand, James C. Reynolds, John W. Greiner, David Colcher, Steven M. Larson, Shashi Shrivastav, Innovations that influence the pharmacology of monoclonal antibody guided tumor targeting. Cancer Research. ,vol. 50, ,(1990)
David A. Scheinberg, Mette Strand, Kinetic and Catabolic Considerations of Monoclonal Antibody Targeting in Erythroleukemic Mice Cancer Research. ,vol. 43, pp. 265- 272 ,(1983)
Ada Sacchi, James Resau, Stephen J. Kennel, Rita Falcioni, Monoclonal Antibody to Human Carcinoma-associated Protein Complex: Quantitation in Normal and Tumor Tissue Cancer Research. ,vol. 48, pp. 816- 821 ,(1988)
David A. Scheinberg, Mette Strand, Radioimmunotherapy in Experimental Animal Models: Principles Derived from Models Cancer Research. ,vol. 50, ,(1990)
David M. Goldenberg, Robert M. Sharkey, Irwin Fand, Use of Whole-Body Autoradiography in Cancer Targeting with Radiolabeled Antibodies Cancer Research. ,vol. 50, ,(1990)
Edward V. Colapinto, Darell D. Bigner, Michael R. Zalutsky, Michael A. Noska, Pradeep K. Garg, Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate. Cancer Research. ,vol. 49, pp. 5543- 5549 ,(1989)
Alan L. Epstein, Feng-Ming Chen, Clive R. Taylor, A novel method for the detection of necrotic lesions in human cancers. Cancer Research. ,vol. 48, pp. 5842- 5848 ,(1988)